Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension
Citation
K. Higashiura et al., Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension, J HUM HYPER, 13, 1999, pp. S71-S74
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
JOURNAL OF HUMAN HYPERTENSION
SICI code
0950-9240(199901)13:<S71:EOAAIR>2.0.ZU;2-L
Abstract
Candesartan (8 mg/d) was administered for 2 weeks to eight patients with es
sential hypertension to investigate the effect of an angiotensin II recepto
r antagonist on insulin sensitivity. The effect of candesartan on sodium-re
taining action and the activation of presser systems by hyperinsulinaemia,
which might be related to presser mechanisms in essential hypertension, was
also investigated in this study, In patients with essential hypertension,
candesartan restored insulin sensitivity to the level of that in normotensi
ve subjects. Candesartan treatment attenuated the sodium-retaining action o
f hyperinsulinaemia. These findings suggest that inhibition of angiotensin
II action by candesartan can improve insulin sensitivity and inhibit the so
dium-retaining action associated with hyperinsulinaemia in essential hypert
ension.